Altered glucose homeostasis, specifically insulin regulation, and impaired glucose tolerance, as well as derangements in lipid metabolism, are consistently reported in FEP populations,55 manifesting as hypertriglyceridemia, insulin resistance, and reduced total and LDL cholesterol levels.56 The gene discussed is INS; the disease is hypertriglyceridemia.